Home Cart Sign in  
Chemical Structure| 122547-49-3 Chemical Structure| 122547-49-3

Structure of Faropenem sodium
CAS No.: 122547-49-3

Chemical Structure| 122547-49-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Faropenem sodium is an antibiotic used to treat infections in the ears, nose, throat, urinary tract, skin, and lungs, caused by bacteria.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Faropenem sodium

CAS No. :122547-49-3
Formula : C12H14NNaO5S
M.W : 307.30
SMILES Code : O=C(C(N12)=C([C@@H]3OCCC3)S[C@]2([H])[C@@H]([C@H](O)C)C1=O)[O-].[Na+]
MDL No. :MFCD01682061

Safety of Faropenem sodium

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
THP-1 monocytes 0, 1.25, 2.5, 5, 10, 20, 40, 80 mg/L 7 days To evaluate the bactericidal effect of Faropenem on intracellular Mycobacterium tuberculosis. Results showed that Faropenem effectively kills intracellular Mtb as monotherapy, with an Emax of 2.71 log10 CFU/mL and an exposure mediating 50% of Emax at 11.09 mg/L. Clin Infect Dis. 2016 Nov 1;63(suppl 3):S95-S101
Mycobacterium tuberculosis SS18b 4 mg/L 21 days To test the activity of tedizolid, moxifloxacin, and faropenem against nonreplicating persisters of Mycobacterium tuberculosis. Results showed that the three-drug combination killed 7.35 log10CFU/ml of nonreplicating persisters in 21 days. Front Pharmacol. 2021 Jan 19;11:616294
Mycobacterium abscessus ATCC 19977 40-80 μg/ml 3 days To evaluate the antimicrobial activity of faropenem against Mycobacterium abscessus ATCC 19977, showing an MIC90 of 40-80 μg/ml. Antimicrob Agents Chemother. 2015 Oct;59(10):6561-7
Mycobacterium tuberculosis H37Rv 2.5-5.0 μg/ml 14 days To evaluate the antimicrobial activity of faropenem against Mycobacterium tuberculosis H37Rv, showing an MIC90 of 2.5-5.0 μg/ml. Antimicrob Agents Chemother. 2015 Oct;59(10):6561-7

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02393586 Tuberculosis Phase 1 Completed - Singapore ... More >> National University Hospital Singapore, Singapore Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.25mL

0.65mL

0.33mL

16.27mL

3.25mL

1.63mL

32.54mL

6.51mL

3.25mL

References

 

Historical Records

Categories